| 000 | 01892 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513175614.0 | ||
| 264 | 0 | _c19990506 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1016/S0009-9236(99)70138-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarditch-Crovo, P | |
| 245 | 0 | 0 |
_aThe effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cApr 1999 |
||
| 300 |
_a428-38 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xpharmacology |
| 650 | 0 | 4 |
_aContraceptives, Oral, Hormonal _xpharmacokinetics |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEthinyl Estradiol _xpharmacokinetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFollicle Stimulating Hormone _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xmetabolism |
| 650 | 0 | 4 |
_aNorethindrone _xpharmacokinetics |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRifabutin _xpharmacology |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_agamma-Glutamyltransferase _xblood |
| 700 | 1 | _aTrapnell, C B | |
| 700 | 1 | _aEtte, E | |
| 700 | 1 | _aZacur, H A | |
| 700 | 1 | _aCoresh, J | |
| 700 | 1 | _aRocco, L E | |
| 700 | 1 | _aHendrix, C W | |
| 700 | 1 | _aFlexner, C | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 65 _gno. 4 _gp. 428-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0009-9236(99)70138-4 _zAvailable from publisher's website |
| 999 |
_c10182912 _d10182912 |
||